Poly-gamma-glutamic acid-containing vaccine

Drug Profile

Poly-gamma-glutamic acid-containing vaccine

Alternative Names: BLS-PGA-C10

Latest Information Update: 15 Jul 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bioleaders Corporation
  • Developer Bioleaders Corporation; CJ HealthCare; Tianjin International Joint Academy of Biotechnology and Medicine
  • Class Cancer vaccines; Glutamates; Peptides
  • Mechanism of Action Immunostimulants; Natural killer cell stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Cervical intraepithelial neoplasia

Most Recent Events

  • 06 Jun 2017 Efficacy data from a phase IIb trial in Cervical intraepithelial neoplasia presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
  • 06 Jun 2017 BioLeaders Corporation initiates enrolment in a phase IIb trial for Cervical intraepithelial neoplasia in South Korea before June 2017
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top